Kaletra (Lopinavir 200 mg / Ritonavir 50 mg) — Patient Information (Australia)

Kaletra is a combination medicine used to treat HIV (human immunodeficiency virus). It contains: lopinavir 200 mg and ritonavir 50 mg in each dose. This combination helps control HIV by blocking the virus from multiplying.

This page explains how Kaletra works, how it is taken, common interactions and safety considerations, and what to expect in day-to-day use. It is written for patient understanding and may not cover every individual situation.

Basic Product Information

• Brand name: Kaletra
• Generic name: Lopinavir / Ritonavir
• Strength (typical tablet combination): Lopinavir 200 mg + Ritonavir 50 mg
• Medicine type: Antiretroviral (protease inhibitor-based) combination therapy
• How it is used: With other HIV medicines (commonly as part of combination therapy)
• Common formulations: Tablets are commonly used; oral solutions may be available depending on availability and patient needs

How Kaletra Works (Mechanism of Action)

HIV relies on an enzyme called protease to make new, mature viral particles. Without this step, new HIV virions cannot properly mature and infect other cells.

• Lopinavir is a protease inhibitor. It blocks HIV protease, preventing the virus from processing proteins required for replication.
• Ritonavir is included in low dose mainly as a pharmacokinetic booster. It helps slow the breakdown of lopinavir, increasing lopinavir levels in the body so it can work effectively.

Together, lopinavir/ritonavir helps reduce the amount of HIV in the body, supporting viral suppression and immune recovery. When taken consistently and as part of a complete regimen, this can reduce HIV-related illness and transmission risk.

Pharmacokinetics (How the Body Handles the Medicines)

“Pharmacokinetics” describes how a medicine is absorbed, distributed, metabolised, and eliminated. Key points for Kaletra include:

• Absorption: Lopinavir/ritonavir absorption is influenced by food. Taking Kaletra with food is important for reliable absorption in many situations.
• Metabolism: Lopinavir and ritonavir are primarily metabolised by liver enzymes (especially CYP3A4 and related pathways). This is a major reason for drug–drug interactions.
• Elimination: The medicines are removed mostly through metabolic processes, with excretion of metabolites. Kidney impairment is generally less important than liver health.
• Boosting effect: Ritonavir raises and stabilises lopinavir concentrations, improving antiviral activity.

Because of variable metabolism and many interactions, it is important to take Kaletra consistently and to discuss other medicines or supplements with a clinician or pharmacist.

What Kaletra Is Used For (Indications)

Kaletra is used in the management of HIV infection in adults and paediatric patients, as determined by clinical guidance. It is used in combination antiretroviral therapy to achieve and maintain viral suppression.

Use may depend on:

• previous HIV treatment history
• test results (e.g., resistance testing)
• other medicines you take
• liver function and overall health

Typical Use and Treatment Expectations

Antiretroviral medicines like Kaletra work best when taken regularly and without missing doses. Viral load typically declines over weeks to months; immune function can improve over time.

Important expectations:

• Consistency matters: irregular dosing increases the risk of incomplete viral suppression.
• Do not stop suddenly: stopping or changing without medical advice can lead to rebound of HIV.
• Monitoring is routine: clinicians usually monitor viral load, CD4 counts, and relevant blood tests.

How to Take Kaletra (Timing and Dosing Principles)

Dosing must be individualised. The information below provides general principles commonly used for Kaletra, including timing with food. Always follow the dosing directions provided by your healthcare professional for your specific regimen.

General timing

• Take with food if possible: Food can improve absorption. Many people take Kaletra with meals (e.g., breakfast and dinner) to reduce stomach upset and improve tolerability.
• Try to take at the same times each day: maintaining steady drug levels supports effectiveness.
• Complete dosing schedule: do not skip doses due to short-term side effects—seek advice instead.

Typical adult dosing (common regimen)

In many adult regimens, Kaletra is taken twice daily. The exact dose depends on the formulation and treatment context. Your clinician may adjust the regimen based on interactions, liver function, and whether other antiretroviral drugs are used.

If you are using Kaletra with other HIV medicines, the overall regimen may be tailored to your viral resistance profile and history.

Dose adjustments and special situations

• Liver impairment: may require caution and potential dose adjustment; clinicians usually assess liver function.
• Drug interactions: certain medicines can raise or lower Kaletra levels, requiring dose changes or avoidance.
• Paediatric dosing: weight-based dosing may be used for children, guided by specialist protocols.

Food Interactions

Food can influence how Kaletra is absorbed. General guidance commonly includes taking it with food to improve reliability of absorption. If you have dietary restrictions or stomach issues, speak with your pharmacist about practical ways to take your dose.

Practical dietary tips

• Choose consistent meal timing: taking Kaletra with meals helps maintain routine.
• Manage nausea: if nausea occurs, taking the dose with a meal (rather than on an empty stomach) may help.
• Avoid extremes: very low-fat or irregular meals may affect absorption in some cases.

If you are also taking supplements or antacids, let your pharmacist confirm whether spacing is needed.

Alcohol and Medicine Interactions

Kaletra contains ritonavir and may interact with alcohol indirectly through liver metabolism. Alcohol may also worsen side effects such as nausea, fatigue, or liver stress.

• General advice: limit alcohol and discuss your alcohol intake with a clinician.
• Liver health: if you have hepatitis or liver disease, alcohol should be avoided or minimised and medical advice is essential.
• Blood sugar considerations: some antiretroviral treatments can indirectly affect metabolism; alcohol may add complexity in people with diabetes.

Always check your full medicine list. Many drug interactions involve common non-prescription products, including cough and cold remedies.

Drug Interactions (Very Important)

Kaletra has a high potential for drug–drug interactions because it affects and is affected by liver enzymes (particularly CYP3A pathways). Interactions can either: reduce HIV treatment effectiveness (leading to viral rebound) or increase risk of side effects (from increased levels of another medicine).

For safety, your pharmacist should review all medicines and supplements, including:

• prescription medicines
• over-the-counter medicines
• herbal products (e.g., St John’s wort)
• vitamins and mineral supplements
• recreational substances (if relevant)

Medicines commonly requiring special caution

The following categories often require avoidance or careful monitoring. Your clinician/pharmacist will provide advice based on your exact medicines:

• Some antiarrhythmics (heart rhythm medicines)
• Some sedatives/sleeping medicines
• Some anticonvulsants
• Some antifungals and antibiotics
• Certain cholesterol-lowering medicines (statins) and lipid treatments
• Drugs for migraine (some “triptans” may interact)
• Herbal supplements such as St John’s wort are generally not recommended with many antiretrovirals

Do not start or stop any medicine without checking interaction risk.

Safety Profile: Common and Serious Side Effects

Like all medicines, Kaletra can cause side effects. Many people experience mild effects that improve with time. However, some side effects can be serious and require prompt medical attention.

Common side effects

• Nausea
• Diarrhoea or stomach discomfort
• Headache
• Fatigue
• Changes in cholesterol or triglycerides (often seen on blood tests)

Important potential serious effects

• Liver problems: tell a clinician promptly if you develop yellowing of the skin/eyes, dark urine, severe fatigue, or abdominal pain.
• Allergic reactions: seek urgent help for rash with swelling, breathing difficulty, or severe dizziness.
• Heart rhythm effects: certain drug combinations can raise risk; report palpitations, fainting, or severe dizziness.
• Immune reconstitution inflammatory syndrome (IRIS): when starting or changing HIV therapy, symptoms of existing infections may temporarily worsen as the immune system recovers.
• Metabolic changes: weight changes, fat distribution changes, and worsening diabetes or insulin resistance may occur with some HIV therapies.

When to seek urgent medical advice

• signs of severe allergic reaction (swelling of face/lips, trouble breathing)
• severe abdominal pain, persistent vomiting, or signs of dehydration
• yellow skin/eyes or very dark urine
• fainting, severe dizziness, chest pain, or irregular heartbeat

Practical Use Tips (How to Get the Best Results)

• Set a routine: choose times that match your meals (e.g., breakfast and dinner) and use alarms if needed.
• Keep a consistent schedule: try not to shift dose timing by many hours from day to day.
• Use with other HIV medicines as instructed: Kaletra is usually part of a combination regimen.
• Track missed doses: if you miss a dose, follow the advice given by your pharmacist/clinic. In general, do not double up unless told to do so.
• Stay hydrated: if diarrhoea occurs, maintain fluid intake and seek advice if it is persistent or severe.
• Monitoring helps: attend blood test appointments (viral load, liver function, lipids, glucose as advised).

Handling side effects

• Diarrhoea: may improve. Avoid dehydration; ask your pharmacist what oral rehydration solutions or anti-diarrhoeal options may be suitable.
• Nausea: taking with food and avoiding very large meals may help.
• Fatigue/headaches: rest, hydration, and discussing persistent symptoms with your clinician can help.

Alternative Options

There are multiple antiretroviral regimens available for HIV. Alternatives may include medicines from different drug classes such as: integrase inhibitors, other protease inhibitors, and non-nucleoside reverse transcriptase inhibitors (NNRTIs).

The best alternative depends on your:

• prior HIV treatment and response
• resistance testing results
• co-infections (e.g., hepatitis)
• other medical conditions (e.g., kidney disease, cardiovascular risk)
• potential drug interactions with your existing medicines

If you’re considering alternatives due to side effects or interactions, ask your pharmacist or HIV clinician to review suitability.

Market and Legal Context for Australia

In Australia, antiretroviral medicines are supplied within a healthcare framework that includes specialist prescribing, dispensing through authorised channels, and medicine safety monitoring. Access may involve:

• pharmacy supply arrangements
• government and program-based support depending on eligibility
• prescribing practices aligned with Australian HIV treatment guidelines

Availability can vary by formulation and distribution channel. An online pharmacy may only supply certain medicines through specific systems that comply with Australian regulatory requirements and applicable prescription/dispensing rules.

Recent Guidance (General Trends in HIV Care)

While individual therapy decisions must be made by clinicians, recent HIV care practices commonly emphasise:

• Rapid viral suppression through modern combination therapy
• Adherence support to maintain durable suppression
• Drug interaction review at initiation and at every change in medicines
• Cardiometabolic risk monitoring (lipids, glucose, cardiovascular risk)

Kaletra may be selected in particular situations, including when clinically appropriate based on prior treatment history and resistance. If you have questions about whether Kaletra remains suitable for you, discuss with your HIV care team rather than changing therapy on your own.

Delivery and Availability in Australia

Availability of Kaletra in Australia can depend on stock levels, formulation (e.g., tablets vs oral solution), and dispensing requirements. For online ordering, typical steps include:

• product availability checks
• processing and verification steps required by local pharmacy systems
• secure delivery within Australia (delivery times vary)

Many pharmacies aim to dispatch within 1–2 business days when stock is available, but delays can occur during high demand or supply chain interruptions. Delivery timelines may also vary by state/territory and courier partner.

If you need urgent continuity of therapy, contact the online pharmacy directly so they can advise on in-stock status and delivery options.

Dosing Summary (Quick Reference)

FAQ: Kaletra (Lopinavir / Ritonavir)

1) Is Kaletra suitable for everyone with HIV?

Kaletra may be suitable for some people, but treatment choice depends on factors like prior HIV therapy, resistance testing, liver health, and other medicines you take. Your HIV care team can determine the most appropriate regimen for you.

2) How soon will Kaletra start working?

Many people see HIV viral load decline within weeks of starting effective therapy. Full response and durability can take longer, and results depend on adherence and your specific regimen.

3) Should I take Kaletra with food?

Taking Kaletra with food is commonly recommended to support absorption and tolerability. Follow your clinician/pharmacist instructions for your particular formulation and schedule.

4) Can I take antacids or other stomach medicines with Kaletra?

Some medicines that affect stomach acidity or contain certain mineral components can interact with absorption or metabolism. Ask your pharmacist about the specific product and whether spacing from Kaletra is needed.

5) What alcohol interactions should I know about?

Alcohol can increase strain on the liver and may worsen side effects. If you drink alcohol, it’s best to discuss the amount with your clinician, especially if you have hepatitis or liver concerns.

6) Are there supplements or herbal products I should avoid?

Herbal products may interact with antiretrovirals. In particular, products such as St John’s wort are commonly not recommended with many HIV medicines due to reduced effectiveness. Always tell your pharmacist about supplements.

7) What should I do if I miss a dose?

The best action depends on how close you are to the next dose and your dosing schedule. Check the advice provided by your pharmacist or clinic. In many cases, doubling up can be risky, so get guidance rather than guessing.

8) What side effects are most common?

Common side effects include nausea, diarrhoea, headache, and fatigue. Changes in cholesterol or triglycerides may also be seen on blood tests. Persistent or severe symptoms should be reviewed promptly.

9) When should I seek urgent help?

Seek urgent medical attention for signs of severe allergic reaction, severe liver problems (e.g., yellowing of the skin/eyes or dark urine), or serious symptoms such as fainting, severe dizziness, or trouble breathing.

10) Can I switch from Kaletra to another HIV medicine?

Switching may be appropriate for some people due to side effects, interactions, or treatment goals. However, changes must be carefully planned based on your resistance profile and overall regimen. Do not stop or switch without your HIV care team’s guidance.

Need Help?

If you have questions about how to take Kaletra, potential interactions with your other medicines, or concerns about side effects, contact a pharmacist or your HIV clinic for advice.